REPL | Replimune Group, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	10.25 - 11.01
52 Week Range	4.92 - 20.05
Beta	0.44
Implied Volatility	406.11%
IV Rank	26.58%
Day's Volume	419,553
Average Volume	1,007,288
Shares Outstanding	68,321,400
Market Cap	708,492,918
Sector	Healthcare
Industry	Biotechnology
IPO Date	2018-07-20

Valuation
Profitability
Growth
Health
P/E Ratio	-3.17
Forward P/E Ratio	N/A
EPS	-3.27
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	331
Country	USA
Website	REPL

Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.

REPL's peers: ASND, CLGN, CRMD, ETON, FDMT, CMPX, GOSS, HRMY, IMRX, IMTX, KALV, KNSA, KPTI, KRON, KROS, KURA, LCTX, LQDA, MDWD, MOR, MRSN, MRUS, MYMD, NUVL, NVCT, PTGX, QURE, RCKT, VTYX, UTHR, LYRA, CERE, AVTE, SNDX, MLYS, CRNX, NAMS, PRTC, RGNX, SRZN, STRO, TECH, TSVT, VCYT, VNDA, VRDN, XBIT, XENE, XNCR, PROK, ELVN

*Chart delayed

Analyzing fundamentals for REPL we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is weak. For more detailed analysis please see REPL Fundamentals page.

Watching at REPL technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on REPL Technicals page.